ClubsMakklerPROMarketsEconomic CalendarEarnings CalendarNewsMakklerAIFamous Investors
ENTRDE
Log InGet Started Free
OverviewStocksCryptoCurrenciesCommoditiesETFsOptionsEconomic CalendarEarnings CalendarGuru PortfoliosMy watchlist

Makkler App

Faster and clearer

Install
Overview/Stocks/IRLA

IRulya Therapeutics Inc. IRLA

NASDAQHealth TechnologyUnited States
$31.00+1.13 (+3.77%)

Market closed· Nov 6, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range
28.8431.10
52-week range
15.10910.00

Financial health

– / 5

Analyst view · 9 firms

Buy9 buy · 0 hold · 0 sell

Avg. target $74.44 (+140.1%)

OverviewFinancialsAnalysisEarningsTechnicalsHistorical dataNews

Prices may be delayed and are for informational purposes only - not investment advice.

IRLA with MakklerAIPRO

Answers from price, statements, peer and news data. Not investment advice.

MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO

Overview
Stocks
Crypto
Currencies
Commodities
ETFs
Options
Economic Calendar
Earnings Calendar
Guru Portfolios
My watchlist
See with MakklerPRO
Details
Clubs
MakklerPRO
Markets
Economic Calendar
Earnings Calendar
News
MakklerAI
Famous Investors
Log In
Get Started Free

The portfolio-sharing platform connecting finance analysts with an audience that wants to learn.

Theme
Platform
ClubsMarketsMarkets NewsMakklerPROMakkler TokenHow It WorksBecome an Analyst
Compare
Makkler vs. eToroMakkler vs. SkoolMakkler vs. YouTube
Company
About UsContact
Legal
Terms of ServicePrivacy PolicyData Protection NoticeRisk DisclosurePayment Policy

© 2026 Makkler, LLC. All rights reserved. Content on this platform does not constitute investment advice.

ENTRDE

Makkler Fair Value

From reported figures and actual prices, no forecasts

Upgrade to MakklerPRO to see the Makkler Fair Value calculation, the fundamental score and the multiples behind it.

Upgrade to MakklerPRO

Financial Health Score

Four areas scored out of 5 by plain rules

Upgrade to MakklerPRO to see a 1-5 score for profitability, growth, cash-flow quality, and balance-sheet health.

Upgrade to MakklerPRO

Analyst opinion

9 brokerages

Strong buy8
Buy1
Hold0
Sell0
Strong sell0

12-month average target price

Price
Low65.00Average74.44 +140.1%High98.00

Peer comparison

Companies in the same sector · ratios from one data provider

CompanyMarket capP/BP/SNet marginRevenue growthDividend yield
IRLAIRulya Therapeutics Inc.$30.81M————0.00%
BCTXBriaCell Therapeutics Corp$31.26M1.90———0.00%
INmune Bio, Inc.$31.36M1.48——-100.0%0.00%
GridAI Technologies Corp.$33.94M2.28191.77-12,990.8%—0.00%
Incannex Healthcare Inc.$27.72M0.41——-100.0%0.00%
Elutia Inc Class A$34.36M2.182.99-184.9%-48.8%0.00%
TransCode Therapeutics, Inc.$26.41M————0.00%
Elicio Therapeutics, Inc$36.30M3.70———0.00%
Polyrizon Ltd.$26.09M0.96———0.00%
Peer median1.9097.38-6,587.8%-100.0%0.00%

Peers are selected automatically from companies in the same industry. Extreme ratios (a loss-making company's P/E, or one distorted by a one-off item) are not adjusted away, which is why the summary row uses the median rather than the average. Not investment advice. The ratios in this table come from one outside provider for every company, so the comparison is internally consistent; they can differ from the filing-derived ratios higher up the page because the definitions differ.

MakklerAI summary

Upgrade to MakklerPRO to see an AI-generated executive summary and bull/bear breakdown built from this stock's financial data.

Upgrade to MakklerPRO
INMB
GRDX
IXHL
ELUT
RNAZ
ELTX
PLRZ